Low dose spiro with 5ARI inhibitor
    Chat 12/20/2024

    From the encyclopedia
    Spironolactone β†’

    powerful topical and oral anti-androgen used mostly by women

    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    Dutasteride β†’

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this question or advice post, the primary subjects mentioned are
    πŸ’Š Spironolactone (oral) low dose
    πŸ’Š Finasteride (oral)
    πŸ’Š Dutasteride (oral)
    the tone is 😐 neutral.

    Other terms

    Spironolactone, finasteride, and dutasteride are discussed for hair maintenance, with concerns about testosterone and side effects like gynecomastia. Spironolactone is noted for use in both bodybuilding and hormone therapy, with low doses considered for minimizing side effects.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Minoxidil: A Comprehensive Review

      research Minoxidil: a comprehensive review

      16 citations , June 2021 in “Journal of Dermatological Treatment”
      This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.
      Dermatosis Associated with Menopause

      research Dermatosis associated with menopause

      10 citations , January 2014 in “Journal of Mid-life Health”
      This article reviews dermatological problems associated with estrogen deficiency in menopausal women and highlights the importance of dermatologist and gynecologist collaboration, but reports no new clinical results.
      Overactive Bladder in Men: Finasteride for Androgenetic Alopecia

      research Overactive bladder in men

      1 citations , January 2009 in “CRC Press eBooks”
      This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.